48 Current news of Merck
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
Expansion creates nearly 500 new jobs in Glasgow and Stirling
02-Jun-2023
Merck invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development and manufacturing process that ensures drugs are safe, efficacious, and meet regulatory requirements. The expansion will create nearly 500 new ...
Supports strategy to add physical capacity and expand regional network in the United States
22-Jul-2022
The Life Science business of Merck broke ground at its Sheboygan, Wisconsin site, for the company’s first lateral flow membrane production facility in the United States. Lateral flow membranes are a key component in rapid diagnostic test kits for a variety of applications, including Covid-19 ...
Once approved, new test will help laboratories increase testing capacity and decrease turnaround time for results
02-Nov-2020
Merck announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, USA, for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test. Mammoth’s high-throughput systems will be compatible with both nasal swab and ...
Merck Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition
02-Jul-2020
Merck enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems, a Meylan, France-based leader in bioprocess analytical monitoring. The company offers Raman spectroscopy analysis through its GMP-ready instrumentation and software. Financial details of the ...
06-Sep-2019
Merck presented Professor David Alsteens (33), Catholic University of Louvain (UCLovain), Louvain-la-Neuve, Belgium with the 2019 Heinrich Emanuel Merck Award for Analytical Science. The award ceremony took place during the analytical conference Euroanalysis at Istanbul University in ...
07-Aug-2019
Merck has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving. Financial details were not disclosed. “BSSN Software and the capabilities that it brings ...
11-Jun-2019
Merck and Rigaku Corp., Tokyo, Japan, have signed a joint development agreement to develop lab consumables based on crystalline sponge technology, which determines the absolute chemical structure of organic molecules and enables X-ray crystallography without crystallization of the analyte. “We ...
Strong organic sales growth impacted by negative exchange rate effects
14-Nov-2018
Merck generated very strong organic sales growth in the third quarter of 2018. However, this was impacted by negative exchange rate effects. Despite organic growth, EBITDA pre of the Group also declined in comparison with the year-earlier quarter owing to strong negative foreign exchange effects. ...
19-Oct-2018
Merck announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for €62.5 million. The closing of the transaction, expected by the end of 2018, is subject to customary closing conditions. Upon completion of the transaction, Luminex will own the flow ...
Prize money up to 1 million Euro
18-Jul-2018
Merck announced a new research prize. The company will award the “Future Insight Prize” of up to € 1 million annually for the next 35 years. The prize will be presented to researchers who will make outstanding contributions to enable innovations important for the future of humanity in the ...
